Dabrafenib + Trametinib in cancer treatment
Dear Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust,
I would be grateful if you could please answer these questions relating to the usage of Dabrafenib + Trametinib in cancer treatment.
A) Over the previous 6 months, how many patients for the following diseases have been treated with a combination of Dabrafenib + Trametinib:
i) Metastatic Melanoma
ii) Adjuvant Melanoma
iii) BRAF mutated Lung Cancer
Many thanks for taking the time to answer these questions.
Yours faithfully,
Oliver Caswell
I am currently out of the office on paternity leave, returning 24 April.
For urgent enquiries relating to communications please contact 01302
644244 or email [email address] or [email address].
Dear Oliver,
Please find attached our response to your Freedom of Information request.
Kind regards,
Diane Wraith
Admin Assistant
Communications and Engagement
Doncaster and Bassetlaw Teaching Hospitals
NHS Foundation Trust
T:01302 644246
E: [1][email address]
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now